These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2243139)

  • 1. CD4-Pseudomonas exotoxin conjugates delay but do not fully inhibit human immunodeficiency virus replication in lymphocytes in vitro.
    Tsubota H; Winkler G; Meade HM; Jakubowski A; Thomas DW; Letvin NL
    J Clin Invest; 1990 Nov; 86(5):1684-9. PubMed ID: 2243139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV effects of CD4-Pseudomonas exotoxin on human lymphocyte and monocyte/macrophage cell lines.
    Ashorn P; Moss B; Berger EA
    Ann N Y Acad Sci; 1990; 616():149-54. PubMed ID: 2078015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors.
    Ashorn P; Moss B; Weinstein JN; Chaudhary VK; FitzGerald DJ; Pastan I; Berger EA
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8889-93. PubMed ID: 1701055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of CD4-Pseudomonas exotoxin against cells expressing diverse forms of the HIV and SIV envelope glycoproteins.
    Ashorn P; Moss B; Berger EA
    J Acquir Immune Defic Syndr (1988); 1992; 5(1):70-7. PubMed ID: 1738090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD4-PE40 is cytotoxic for a transfected mammalian cell line stably expressing the envelope protein of human immunodeficiency virus (HIV-1), and cytotoxicity is variably inhibited by the sera of HIV-1-infected patients.
    Pitts TW; Bohanon MJ; Leach MF; McQuade TJ; Marschke CK; Merritt JA; Wierenga W; Nicholas JA
    AIDS Res Hum Retroviruses; 1991 Sep; 7(9):741-50. PubMed ID: 1742081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a soluble CD4 and CD4-Pseudomonas exotoxin A chimeric protein on human peripheral blood lymphocytes: lymphocyte activation and anti-HIV activity in vitro.
    Rubino KL; Tarpley WG; Nicholas JA
    Antiviral Res; 1991 Oct; 16(3):267-79. PubMed ID: 1805685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4-Pseudomonas exotoxin hybrid proteins: modulation of potency and therapeutic window through structural design and characterization of cell internalization.
    Winkler G; Jakubowski A; Turner S; Liu T; Burrus B; McGray P; Heanue T; Rosa M; Griffiths BA; Wali A
    AIDS Res Hum Retroviruses; 1991 Apr; 7(4):393-401. PubMed ID: 2069820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary HIV-1 isolates refractory to neutralization by soluble CD4 are potently inhibited by CD4-Pseudomonas exotoxin.
    Kennedy PE; Moss B; Berger EA
    Virology; 1993 Jan; 192(1):375-9. PubMed ID: 8517027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.
    Berger EA; Clouse KA; Chaudhary VK; Chakrabarti S; FitzGerald DJ; Pastan I; Moss B
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9539-43. PubMed ID: 2480605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HIV activity of CD4-Pseudomonas exotoxin on infected primary human lymphocytes and monocyte/macrophages.
    Ashorn P; Englund G; Martin MA; Moss B; Berger EA
    J Infect Dis; 1991 Apr; 163(4):703-9. PubMed ID: 2010626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells.
    Fang H; Pincus SH
    J Virol; 1995 Jan; 69(1):75-81. PubMed ID: 7983770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas exotoxin and recombinant immunotoxins derived from it.
    Fitzgerald D; Pastan I
    Ann N Y Acad Sci; 1993 Jun; 685():740-5. PubMed ID: 8363279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and enhanced cytotoxicity of a [cyanovirin-N]-[Pseudomonas exotoxin] conjugate against human immunodeficiency virus-infected cells.
    Mori T; Shoemaker RH; McMahon JB; Gulakowski RJ; Gustafson KR; Boyd MR
    Biochem Biophys Res Commun; 1997 Oct; 239(3):884-8. PubMed ID: 9367864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas exotoxin A: from virulence factor to anti-cancer agent.
    Wolf P; Elsässer-Beile U
    Int J Med Microbiol; 2009 Mar; 299(3):161-76. PubMed ID: 18948059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel composite immunotoxin that suppresses rabies virus production by the infected cells.
    Mareeva T; Wanjalla C; Schnell MJ; Sykulev Y
    J Immunol Methods; 2010 Feb; 353(1-2):78-86. PubMed ID: 19932697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotoxins directed against the high-molecular-weight melanoma-associated antigen. Identification of potent antibody-toxin combinations.
    Godal A; Kumle B; Pihl A; Juell S; Fodstad O
    Int J Cancer; 1992 Oct; 52(4):631-5. PubMed ID: 1399146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a genetic immunotoxin to eliminate toxin immunogenicity.
    Chen SY; Zani C; Khouri Y; Marasco WA
    Gene Ther; 1995 Mar; 2(2):116-23. PubMed ID: 7719928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.
    Weldon JE; Pastan I
    FEBS J; 2011 Dec; 278(23):4683-700. PubMed ID: 21585657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of Diphtheria and Pseudomonas Exotoxin A Immunotoxins and Evaluation of Their Cytotoxicity Effect on SK-BR-3, BT-474, and MDA-MB-231 Breast Cancer Cell Lines.
    Amoozadeh S; Hemmati M; Farajollahi MM; Akbari N; Tarighi P
    Cancer Invest; 2019; 37(10):546-557. PubMed ID: 31597492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A.
    Kaplan G; Lee F; Onda M; Kolyvas E; Bhardwaj G; Baker D; Pastan I
    Toxins (Basel); 2016 Jul; 8(8):. PubMed ID: 27463727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.